MARGARET WRAY: Open Payments
NPI 1659060812 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 50 payments from 23 companies in 2025. Trend: 2023 $88 · 2024 $591 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $198 |
| ABBVIE INC. | 4 | $112 |
| PFIZER INC. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Daiichi Sankyo Inc. | 3 | $52 |
| Agios Pharmaceuticals, Inc. | 2 | $39 |
| BeOne Medicines USA, Inc. | 2 | $32 |
| Gilead Sciences, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $29 |
Products named: IBRANCE, VENCLEXTA, ERLEADA, Enhertu, TECVAYLI, DARZALEX, PYRUKYND, RYBREVANT.
Industry payments across GA — which companies pay providers there.
